Carlsmed, Inc. (CARL)
| Market Cap | 322.17M |
| Revenue (ttm) | 32.27M |
| Net Income (ttm) | -25.72M |
| Shares Out | 26.52M |
| EPS (ttm) | -1.11 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 105,007 |
| Open | 11.99 |
| Previous Close | 12.11 |
| Day's Range | 11.83 - 12.20 |
| 52-Week Range | 11.81 - 15.20 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About CARL
Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies. Its product includes aprevo, a medical platform that makes surgical plans and devices tailored to the precise medical situation of every individual patient. It provides New Technology Add-On Payment (NTAP) reimbursement. The company was incorporated in 2018 and is based in Carlsbad, California. [Read more]
News
Carlsmed's aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures
CARLSBAD, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (“Carlsmed”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that in the Ho...
Carlsmed's aprevo® Powers First Personalized Cervical Spine Surgery
CARLSBAD, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced...
Carlsmed: Spine Play Does Not Have My Backing Yet
Carlsmed's IPO debut is steady, with shares trading near the offering price, reflecting investor caution on its one-product, loss-making business model. Despite doubling sales and manageable cash burn...
Carlsmed Announces Pricing of Initial Public Offering
CARLSBAD, Calif.--(BUSINESS WIRE)--Carlsmed, Inc. (“Carlsmed”), a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced the pricing of...
Carlsmed Announces Launch of Initial Public Offering
CARLSBAD, Calif.--(BUSINESS WIRE)--Carlsmed, Inc. (“Carlsmed”), a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced the launch of ...
U.S. IPO Weekly Recap: Mining Companies Lead The Calendar As More Sizable IPOs Submit Initial Filings
Six issuers debuted in the US this past week, led by two mining companies. Three blank check companies also went public, and a handful of notable IPO candidates joined the pipeline. Four sizable IPOs ...
Carlsmed Files For IPO On High Growth And High Operating Losses
Carlsmed, Inc. has filed to raise $100 million in a U.S. IPO, but the final figure may differ. The company targets a large, but moderately growing spinal surgery market, with expansion plans in cervic...
Spine surgery-focused medtech Carlsmed files for a $100 million IPO
Carlsmed, which provides custom equipment and AI-enabled software for personalized spine fusion surgery, filed on Thursday with the SEC to raise up to $100 million in an initial public offering.
Carlsmed Announces Filing of Registration Statement for Proposed Initial Public Offering
Carlsmed, Inc., a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that i...
Carlsmed IPO Registration Document (S-1)
Carlsmed has filed to go public with an IPO on the NASDAQ.